These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37578746)

  • 1. Meta-analysis of proton pump inhibitor use and the risk of developing gastric cancer or colorectal cancer.
    Liu K; Wang YH; Wang J; Chen B; Luo N; Gong J
    Anticancer Drugs; 2023 Oct; 34(9):971-978. PubMed ID: 37578746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis.
    Guo H; Zhang R; Zhang P; Chen Z; Hua Y; Huang X; Li X
    Front Pharmacol; 2023; 14():1129948. PubMed ID: 37007006
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis.
    Jiang K; Jiang X; Wen Y; Liao L; Liu FB
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1898-1905. PubMed ID: 31206764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proton pump inhibitors for the risk of gastric cancer.
    Gao H; Li L; Geng K; Teng C; Chen Y; Chu F; Zhao Y
    Medicine (Baltimore); 2022 Dec; 101(49):e32228. PubMed ID: 36626449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis.
    Peng TR; Wu TW; Li CH
    Int J Clin Oncol; 2023 Jan; 28(1):99-109. PubMed ID: 36224477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA
    Am J Gastroenterol; 2020 May; 115(5):706-715. PubMed ID: 32205645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies.
    Pan S; Thrift AP; Akhdar G; El-Serag HB
    Dig Dis Sci; 2023 Sep; 68(9):3732-3744. PubMed ID: 37432532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
    Ma T; Wu M; Jia S; Yang L
    Int J Colorectal Dis; 2020 Dec; 35(12):2157-2169. PubMed ID: 32808072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers.
    Zeng R; Cheng Y; Luo D; Wang J; Yang J; Jiang L; Zhuo Z; Guo K; Wu H; Leung FW; Sha W; Chen H
    Eur J Cancer; 2021 Oct; 156():190-201. PubMed ID: 34481369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.
    Ahn JS; Eom CS; Jeon CY; Park SM
    World J Gastroenterol; 2013 Apr; 19(16):2560-8. PubMed ID: 23674860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
    Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
    Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
    Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intake of Proton-Pump Inhibitors and Gastric Cancer within the Stomach Cancer Pooling (StoP) Project.
    Sassano M; Mariani M; Pelucchi C; Lunet N; Morais S; Martín V; Moreno V; Curado MP; Dias-Neto E; Leja M; Gašenko E; La Vecchia C; Boccia S; Pastorino R
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1174-1181. PubMed ID: 37364052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
    Xiong J; Lai S; Zhang P; Li Q; Wei Y; Yang Y; Wang T; Liu L; Ma X; Chen D
    Medicine (Baltimore); 2014 Sep; 93(12):e64. PubMed ID: 25211045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitors and Cancer Risk: An Umbrella Review and Meta-analysis of Observational Studies.
    Zhang ML; Fan YX; Meng R; Cai WK; Yin SJ; Zhou T; Huang YH; Wang P; Jiang FF; Yang M; He GH
    Am J Clin Oncol; 2022 Nov; 45(11):475-485. PubMed ID: 36255347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis.
    Song HJ; Jeon N; Squires P
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1437-1456. PubMed ID: 32548678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.